Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India
- 13 February 2007
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 36 (3), 136-141
- https://doi.org/10.1111/j.1600-0714.2006.00505.x
Abstract
The advent of highly active antiretroviral therapy (HAART) has changed the scenario of human immunodeficiency virus (HIV) infection. HIV patients in India have now access to generic HAART and this is the first report describing oral lesions in patients on HAART from our country. Oral lesions were studied in HIV seropositive patients (n = 50 on HAART and n = 50 not on HAART) attending a tertiary HIV referral care centre in India and patients on HAART were followed up. There was a difference in the occurrence of oral candidiasis (OC) between HAART and non-HAART participants (8%, 24%; P < 0.05). Pseudomembranous candidiasis was 4% and 18% in HAART and non-HAART groups respectively (P < 0.05). In patients with CD4 count 200, pigmentation was 43.8% in the HAART group and 14.8% in the non-HAART group (P < 0.05). The prevalence of OC in patients who had access to HAART was less when compared with those who did not have access to HAART.This publication has 31 references indexed in Scilit:
- Oral Candidosis as a Clinical Marker of Immune Failure in Patients with HIV/AIDS on HAARTAIDS Patient Care and STDs, 2005
- Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patientsOral Diseases, 2004
- Effect of PI‐HAART on the prevalence of oral lesions in HIV‐1 infected patients. A Greek studyOral Diseases, 2004
- Oral manifestations of an HIV positive cohort in the era of highly active anti‐retroviral therapy (HAART) in South LondonJournal of Oral Pathology & Medicine, 2002
- Human Papillomavirus-Associated Oral Warts among Human Immunodeficiency Virus-Seropositive Patients in the Era of Highly Active Antiretroviral Therapy: An Emerging InfectionClinical Infectious Diseases, 2002
- Antiretroviral Therapy with Protease Inhibitors Has an Early, Immune Reconstitution–Independent Beneficial Effect onCandidaVirulence and Oral Candidiasis in Human Immunodeficiency Virus–Infected SubjectsThe Journal of Infectious Diseases, 2002
- Oral Lesions in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment Including Protease Inhibitors: A New Face of Oral AIDS?AIDS Patient Care and STDs, 2000
- Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapyJournal of Oral Pathology & Medicine, 2000
- Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasisAIDS, 2000
- Classification and diagnostic criteria for oral lesions in HIV infectionJournal of Oral Pathology & Medicine, 1993